Abstract: Infective dermatitis is a chronic exudative eczematous eruption presenting in human T-lymphotropic virus type 1 (HTLV-1)-infected people. It presents with relapsing erythematous, scaly, and crusted lesions affecting simultaneously the scalp, external ear, retroauricular area, eyelid, paranasal skin, neck axilla, and groin. Superimposed Staphylococcus and Streptococcus infection are common. It mainly affects children and exceptionally adults, and there are only a few published cases. The authors present the first reported case in Paraguay of an adult patient who had symptoms of human Tlymphotropic virus type 1-associated progressive tropical spastic paraparesis, and 6 years after the onset of the neurological symptoms, the patient developed infective dermatitis lesions on the skin, with frequent exacerbations since then.
INTRODUCTION
Human T-lymphotropic virus type 1 (HTLV-1) was the first human retrovirus with demonstrated oncogenic potential. Its infection exists worldwide, and it is estimated that about 20 million people are infected but only 5% of them developed any pathology. Different diseases have been associated with HTLV-1. The first identified was adult T-cell leukemia-lymphoma (ATLL), confirmed by the demonstration of monoclonal integration of proviral DNA into the genome of neoplastic cells. Later on, a type of spastic paraparesis called tropical spastic paraparesis (TSP) was identified, generally regarded as an expression of acquired infection in adult life. 1, 2 In 1980, Poiesz et al in the United States identified and isolated the first human retrovirus in a patient with cutaneous T-cell lymphoma. In 1985, Gessain et al 3 found antibodies against HTLV-1 in patients with myelopathy and spastic paraparesis who were carriers of the virus, which led to establish the double pathological role of this virus. [4] [5] [6] In 1966, Sweet 7 reported in Jamaica the first case of infective dermatitis (ID) in children. In 1967, Walshe documented the clinical and biological features of the disease in 25 Jamaican children, noting its association with malnutrition and infection by Staphylococcus aureus and Streptococcus beta hemolyticus with poor response to antibiotic treatment, postulating that malnutrition resulted in immunosuppression. In 1990, LaGrenade et al defined ID as an early marker for HTLV-1. Years later, it was determined that ID does not only belong to children. [8] [9] [10] We present the first case described in our country of ID and spastic paraparesis in a patient with HTLV-1 infection.
CASE REPORT
A 40-year-old man who is a painter, single, from an urban area of Paraguay with no vicious habits followed by the Neurology service for 10 years for symptoms of HTLV-1-related progressive TSP, treated with prednisone 50 mg once daily and then gradually decreased, and then with pregabalin 75 mg once daily, gabapentin 800 mg once daily, and baclofen 10 mg once daily.
He consulted the Dermatology service for dry skin, markedly predominant in extremities, and generalized itching of 3-month duration.
On physical examination, there are erythematous, scaly, eroded, and crusted patches with jagged edges, fuzzy boundaries spread over face, neck, trunk, and extremities, predominantly in lower back, thighs, knees, and flexures. Lichenification areas are also present (Figs. 1-3 ).
Histopathology of 3 Skin Sites 
Final Diagnosis: ID and Spastic Paraparesis in an Adult Patient With HTLV-1 Evolution
The patient was treated for the dermatological symptoms with emollients, topical corticosteroids, oral antihistamines, and topical and oral antibiotics, plus topical antifungal because of a frequent association of this entity with intertrigo. The patient had several referrals to the emergency room of our hospital for fever and two episodes of sepsis that started in the skin in October, 2013 and June, 2014. On both times, a MRSA 3/3 was isolated from blood cultures, and in the last episode, the same germ was found in urine culture. He also had a crusted scabies outbreak and intertrigo with good response to systemic antibiotics, ivermectin, and topical and oral antifungal therapy.
COMMENTS
HTLV-1 is a cosmopolitan virus, although its highest prevalence is found in some regions such as Asia (especially Japan), Africa, the Caribbean, and South America (Argentina, Bolivia, Brazil, Colombia, Chile, Ecuador, Peru, Venezuela). In our continent, Brazil, in its northern area, is probably the country with the highest absolute number of infected people. Some cases have also been detected in Paraguay. 1, 4, 11, 12 Just like it happens with other retroviruses, transmission can be through (1) sexual contact, with highest seroprevalence in female sex workers (2.8%-5.7%), (2) transfusions (intravenous drug users), with a seroconversion of 40%-60% among exposed subjects in a 60-day period, and (3) vertical transmission (transplacental, birth canal, and especially with breastfeeding). The more the breastfeeding time and maternal viral load are the more the likelihood of transmission is. Children get infected fundamentally through breast milk, unlike with HIV. 1, 2, 13, 14 Not all people infected with HTLV-1 will develop complications, and up to 90% of HTLV-1 carriers remain asymptomatic. However, the remaining 10% develop HTLV-1-associated diseases. Some of those associated diseases could be very severe, like ATLL and TSP/HTLVassociated myelopathy.
When function and reproduction of T cells are interfered by HTLV-1, it can cause several diseases, separated in three categories: (1) neoplasms: mainly ATLL, (2) inflammatory syndromes: TSP, uveitis, thyroiditis, and alveolitis, (3) complications: infections, including strongyloidiasis, scabies, tuberculosis, and ID. 15, 16 ID affects mainly children, and the characteristic feature is the presence of desquamation and exudation, with persistent purulent cutaneous infections. Most common locations include the scalp, skin folds (retroauricular, axillae, and groin), nares, neck, and umbilicus. It has mild-to-moderate pruritus and adenopathy. Sometimes, it can be associated with blepharoconjunctivitis. In skin cultures, S. aureus and/or beta hemolytic Streptococci are frequently found (94% of cases), and they usually relapse after discontinuation of the antibiotic. 1, 11, 13, 17, 18 Histopathology study of ID is not specific and it reveals acanthosis, with mild-to-moderate spongiosis, and occasional conglomerates of neutrophils in the stratum corneum. Dermis observation shows lymphocyte infiltrates of liquenoid or superficial perivascular type. A small number of cases could present lymphocytic epidermotropism, with or without atypical lymphocytes. Immunohistochemistry reveals major positivity for CD8 and CD57. These morphological findings, along with negativity for CD7 (mature T cell), are very similar to the ones observed in the early stages of ATLL. This leads some authors to suggest that ID could be an early stage of ATLL. It is suggested that ID could be a marker of more severe associated diseases such as ATLL and TSP. 1, 11, 13, 14, 19, 20 ID is primarily diagnosed clinically; differential diagnosis includes atopic dermatitis and seborrheic dermatitis.
There are major and minor diagnosis criteria. Four of 5 major criteria are required, and 1, 2 and 5 are mandatory. 1, 9, 13, 14, 20 Of the 5 major criteria, 4 are required for diagnosis, being 1, 2, and 5 mandatory. To fulfill the first major criteria, it must be present in at least 2 of the 7 locations. Our patient presented 3 major criteria (1, 3, and 5) and all minor criteria. Although ID is an infancy pathology, there are a few cases in adults published. Our patient developed dermatosis in the adult age, and the presence of HTLV-1 virus in the blood was demonstrated.
In regard to the second major criteria, this case did not present with rhinorrhea or crusting of the anterior nares. However, a series of 15 patients where the absence of this sign would not invalidate diagnosis was recently published.
The authors suggest that this criteria could be considered transient, therefore, not mandatory. 1, 13 Diagnosis requires serologic confirmation with ELISA, Western blot, Polimerasa chain reaction, or Southern blot, with higher titers having the worst prognosis. The presence of antibodies against proteins p24, p19, rgp46-1, and rgp21 is required. It is complemented with polimerasa chain reaction of blood, cerebro spinal fluid, or tissue sample (skin, lymph node), especially if serology is not conclusive. 
Major Criteria
Dermatitis of the scalp, external ear, retroauricular area, eyelid margins, paranasal skin, neck, axillae, or groin Chronic watery nasal discharge and/or crusting of the anterior nares Chronic relapsing dermatitis that responds quickly to antibiotics but relapses promptly after withdrawal Onset during early childhood Seropositivity for HTLV-1
Minor Criteria
Positive cultures for S. aureus and/or beta hemolytic Streptococci from the skin or anterior nares Generalized fine papular rash Generalized lymphadenopathy with dermatopathic lymphadenitis Anemia Elevated erythrocyte sedimentation rate Hyperimmunoglobulinemia (IgE and IgD) Elevated CD4 and CD8 T-cell counts There is no specific treatment. Antiretroviral schemes such as the use of AZT have not been sufficiently effective. Each clinical presentation has a special approach. For ID, exudative type treatment is used; it includes topical steroids and antistaphylococcal antibiotics. 1, 4, 6 The best way to approach this is with prevention, eliminating transmission factors with blood donor screening, avoiding breastfeeding in infected mothers, using barrier protection during sexual intercourse, educating on how the virus is transmitted, early serologic detection, and elective c-section in seropositive women. There is no specific vaccine. 1, 4, 6, 14 We believe that it is important to present the first case of an adult patient with ID and TSP/HTLV-associated myelopathy in the country. HTLV-1 is an emergent virus with marked cutaneous tropism, and knowledge on this subject should be shared among the dermatology field.
